{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:19:38Z","timestamp":1790543978957,"version":"4.1.0"},"reference-count":241,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00191","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T14:52:16Z","timestamp":1581691936000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation"],"prefix":"10.3389","volume":"11","author":[{"given":"Susanne H. C.","family":"Baumeister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman M.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Romee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1182\/blood-2014-10-604785","article-title":"Biological significance of HLA locus matching in unrelated donor bone marrow transplantation","volume":"125","author":"Morishima","year":"2015","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1182\/asheducation.V2012.1.230.3798312","article-title":"Haploidentical transplantation for hematologic malignancies: where do we stand?","volume":"2012","author":"Fuchs","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"B5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S0140-6736(83)91793-2","article-title":"Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia","volume":"1","author":"Powles","year":"1983","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJM198509263131301","article-title":"Marrow transplantation from related donors other than HLA-identical siblings","volume":"313","author":"Beatty","year":"1985","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0198-8859(90)90071-V","article-title":"Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma","volume":"29","author":"Anasetti","year":"1990","journal-title":"Hum Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1182\/blood.V61.2.341.341","article-title":"Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells","volume":"61","author":"Reisner","year":"1983","journal-title":"Blood."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/nm1295-1268","article-title":"Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice","volume":"1","author":"Bachar-Lustig","year":"1995","journal-title":"Nat Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1749-6632.1999.tb08478.x","article-title":"The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation","volume":"872","author":"Reisner","year":"1999","journal-title":"Ann N Y Acad Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"key":"B12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1586905","DOI":"10.1155\/2018\/1586905","article-title":"High-risk leukemia: past, present, and future role of NK cells","volume":"2018","author":"Mavers","year":"2018","journal-title":"J Immunol Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.bbmt.2009.01.019","article-title":"Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses","volume":"15","author":"Gill","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/cancers11060769","article-title":"Natural killer cells as allogeneic effectors in adoptive cancer immunotherapy","volume":"11","author":"Lupo","year":"2019","journal-title":"Cancers."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.3324\/haematol.2017.176107","article-title":"Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"102","author":"Lee","year":"2017","journal-title":"Haematologica."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3389\/fimmu.2019.01854","article-title":"Adoptive T cell therapy following haploidentical hematopoietic stem cell transplantation","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/cells8010047","article-title":"Adoptive T cell therapy strategies for viral infections in patients receiving haematopoietic stem cell transplantation","volume":"8","author":"Ottaviano","year":"2019","journal-title":"Cells."},{"key":"B19","first-page":"2701","article-title":"T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect","volume":"19","author":"Henslee","year":"1987","journal-title":"Transplant Proc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings","volume":"15","author":"Szydlo","year":"1997","journal-title":"J Clin Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1182\/blood.V68.3.770.770","article-title":"Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease","volume":"68","author":"Kernan","year":"1986","journal-title":"Blood."},{"key":"B22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/00007890-198743060-00014","article-title":"Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes","volume":"43","author":"Kernan","year":"1987","journal-title":"Transplantation."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.83.11.4012","article-title":"Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation","volume":"83","author":"Reisner","year":"1986","journal-title":"Proc Natl Acad Sci USA."},{"key":"B24","first-page":"443","article-title":"Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion","volume":"7","author":"Ash","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"B25","first-page":"55","article-title":"HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease","volume":"19","author":"O'Reilly","year":"1987","journal-title":"Transplant Proc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1056\/NEJM198901263200401","article-title":"Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma","volume":"320","author":"Anasetti","year":"1989","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/00007890-199805270-00017","article-title":"Tolerance induction by \u201cmegadose\u201d hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture","volume":"65","author":"Rachamim","year":"1998","journal-title":"Transplantation."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1182\/blood-2002-11-3463","article-title":"Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha","volume":"105","author":"Gur","year":"2005","journal-title":"Blood."},{"key":"B31","first-page":"3101","article-title":"Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results","volume":"28","author":"Terenzi","year":"1996","journal-title":"Transplant Proc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \u201cthree-loci\u201d incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood."},{"key":"B33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/200084a0","article-title":"Prolongation of homograft survival in mice with single doses of cyclophosphamide","volume":"200","author":"Berenbaum","year":"1963","journal-title":"Nature."},{"key":"B34","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.4049\/jimmunol.157.7.2820","article-title":"Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach","volume":"157","author":"Colson","year":"1996","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.4049\/jimmunol.155.9.4179","article-title":"A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers","volume":"155","author":"Colson","year":"1995","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.seminhematol.2016.01.005","article-title":"Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide","volume":"53","author":"Robinson","year":"2016","journal-title":"Semin Hematol."},{"key":"B37","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.149.8.2668","article-title":"Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A","volume":"149","author":"Nomoto","year":"1992","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3181\/00379727-133-34456","article-title":"Prevention of cyclophosphamide-induced tolerance to erythrocytes by pretreatment with cortisone","volume":"133","author":"Dukor","year":"1970","journal-title":"Proc Soc Exp Biol Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.bbmt.2013.06.019","article-title":"Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation","volume":"19","author":"Ross","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B40","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.146.5.1402","article-title":"Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice","volume":"146","author":"Eto","year":"1991","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/eji.1830200919","article-title":"The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance","volume":"20","author":"Eto","year":"1990","journal-title":"Eur J Immunol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.4049\/jimmunol.145.5.1303","article-title":"Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion","volume":"145","author":"Eto","year":"1990","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1084\/jem.171.1.97","article-title":"Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens","volume":"171","author":"Eto","year":"1990","journal-title":"J Exp Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41409-019-0615-0","article-title":"Post-transplantation cyclophosphamide for chimerism-based tolerance","volume":"54","author":"McCurdy","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B45","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.4049\/jimmunol.157.12.5284","article-title":"Regulatory T cells in maintenance and reversal of peripheral tolerance in vivo","volume":"157","author":"Kong","year":"1996","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4049\/jimmunol.144.2.463","article-title":"Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?","volume":"144","author":"Tomita","year":"1990","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1172\/JCI124218","article-title":"Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression","volume":"130","author":"Wachsmuth","year":"2019","journal-title":"J Clin Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci Transl Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1182\/blood-2013-10-525873","article-title":"Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice","volume":"124","author":"Ganguly","year":"2014","journal-title":"Blood."},{"key":"B50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O'Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant."},{"key":"B51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.seminhematol.2016.01.004","article-title":"Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience","volume":"53","author":"Chang","year":"2016","journal-title":"Semin Hematol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","article-title":"Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?","volume":"98","author":"Korbling","year":"2001","journal-title":"Blood."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1182\/blood.V95.8.2484","article-title":"Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells","volume":"95","author":"Arpinati","year":"2000","journal-title":"Blood."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1182\/blood.V86.12.4422.bloodjournal86124422","article-title":"Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease","volume":"86","author":"Pan","year":"1995","journal-title":"Blood."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1182\/blood.V89.5.1629","article-title":"Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells","volume":"89","author":"Mielcarek","year":"1997","journal-title":"Blood."},{"key":"B57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1182\/blood.V91.1.347","article-title":"Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells","volume":"91","author":"Tanaka","year":"1998","journal-title":"Blood."},{"key":"B58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood.V92.1.215.413k10_215_222","article-title":"Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation","volume":"92","author":"Mielcarek","year":"1998","journal-title":"Blood."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1182\/blood.V98.12.3186","article-title":"Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells","volume":"98","author":"Morton","year":"2001","journal-title":"Blood."},{"key":"B60","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1021\/ja050412d","article-title":"A direct comparison of one- and two-component dendritic self-assembled materials: elucidating molecular recognition pathways","volume":"127","author":"Huang","year":"2005","journal-title":"J Am Chem Soc."},{"key":"B61","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1532\/IJH97.A10227","article-title":"Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect","volume":"79","author":"Chen","year":"2004","journal-title":"Int J Hematol."},{"key":"B62","first-page":"787","article-title":"Effects of rhG-CSF mobilization on immunological properties of grafts from peripheral blood and bone marrow","volume":"14","author":"Zhao","year":"2006","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","article-title":"Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study","volume":"125","author":"Wang","year":"2015","journal-title":"Blood."},{"key":"B64","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1038\/bmt.2015.91","article-title":"Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update","volume":"50","author":"Arcese","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B65","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","article-title":"Who is the best donor for a related HLA haplotype-mismatched transplant?","volume":"124","author":"Wang","year":"2014","journal-title":"Blood."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/S0140-6736(80)92394-6","article-title":"Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin","volume":"2","author":"Reisner","year":"1980","journal-title":"Lancet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1073\/pnas.75.6.2933","article-title":"Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins","volume":"75","author":"Reisner","year":"1978","journal-title":"Proc Natl Acad Sci USA."},{"key":"B68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0140-6736(81)90647-4","article-title":"Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells","volume":"2","author":"Reisner","year":"1981","journal-title":"Lancet."},{"key":"B69","first-page":"387","article-title":"Positive stem cell selection\u2013basic science","volume":"333","author":"Civin","year":"1990","journal-title":"Prog Clin Biol Res."},{"key":"B70","first-page":"2818","article-title":"Peripheral blood stem cell mobilization after stem cell factor or G-CSF treatment: rapid enrichment for stem and progenitor cells using the CEPRATE immunoaffinity separation system","volume":"24","author":"Heimfeld","year":"1992","journal-title":"Transplant Proc."},{"key":"B71","first-page":"303","article-title":"The efficiency of a new cell separation technique in bone marrow purging without damaging the purged tumor cells","volume":"333","author":"Handgretinger","year":"1990","journal-title":"Prog Clin Biol Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science."},{"key":"B73","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/sj.bmt.1702996","article-title":"Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children","volume":"27","author":"Handgretinger","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"B74","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1055\/s-2005-872530","article-title":"Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update","volume":"217","author":"Feuchtinger","year":"2005","journal-title":"Klin Padiatr."},{"key":"B75","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1055\/s-2005-872529","article-title":"A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study","volume":"217","author":"Lang","year":"2005","journal-title":"Klin Padiatr."},{"key":"B76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.humimm.2019.03.003","article-title":"B cells in chronic graft-versus-host disease","volume":"80","author":"McManigle","year":"2019","journal-title":"Hum Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.bbmt.2018.02.026","article-title":"Epstein-barr virus-related post-transplantation lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Liu","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B78","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/bmt.2016.19","article-title":"Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT","volume":"51","author":"Burns","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3324\/haematol.2011.059378","article-title":"Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3\/CD19 depletion and reduced intensity conditioning: a phase II study","volume":"97","author":"Federmann","year":"2012","journal-title":"Haematologica."},{"key":"B80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bcmd.2007.07.001","article-title":"Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3\/CD19 depletion and reduced intensity conditioning: an update","volume":"40","author":"Bethge","year":"2008","journal-title":"Blood Cells Mol Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1182\/blood-2017-08-752162","article-title":"The potential role of gammadelta T cells after allogeneic HCT for leukemia","volume":"131","author":"Handgretinger","year":"2018","journal-title":"Blood."},{"key":"B82","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/bbmt.1999.v5.pm10465102","article-title":"Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs","volume":"5","author":"Drobyski","year":"1999","journal-title":". Biol Blood Marrow Transplant."},{"key":"B83","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/35105052","article-title":"Autoreactivity by design: innate B and T lymphocytes","volume":"1","author":"Bendelac","year":"2001","journal-title":"Nat Rev Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.immuni.2009.08.006","article-title":"Gammadelta T cells and the lymphoid stress-surveillance response","volume":"31","author":"Hayday","year":"2009","journal-title":"Immunity."},{"key":"B85","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1586\/14737140.5.6.973","article-title":"Peripheral gammadelta T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma","volume":"5","author":"Viey","year":"2005","journal-title":"Expert Rev Anticancer Ther."},{"key":"B86","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.4049\/jimmunol.175.8.5481","article-title":"V gamma 9V delta 2 T cell response to colon carcinoma cells","volume":"175","author":"Corvaisier","year":"2005","journal-title":"J Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2741\/1556","article-title":"Synergism and complementarity between human CD1 AND MHC-restricted T cells, two lymphoid subsets directed against distinct antigenic worlds","volume":"10","author":"Bonneville","year":"2005","journal-title":"Front Biosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1086\/323600","article-title":"Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9\/Vdelta2 T lymphocytes","volume":"184","author":"Dieli","year":"2001","journal-title":"J Infect Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.4049\/jimmunol.177.8.5533","article-title":"Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suis","volume":"177","author":"Dudal","year":"2006","journal-title":"J Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbmt.2014.09.027","article-title":"Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia","volume":"21","author":"Perko","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B91","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"B92","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/scd.1.1996.5.503","article-title":"Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia","volume":"5","author":"Lamb","year":"1996","journal-title":"J Hematother."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1182\/blood-2014-09-599423","article-title":"\u03b3\u03b4 T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-\u03b1\u03b2+\/CD19+ lymphocytes","volume":"125","author":"Airoldi","year":"2015","journal-title":"Blood."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e1216291","DOI":"10.1080\/2162402X.2016.1216291","article-title":"Zoledronic acid boosts gammadelta T-cell activity in children receiving alphabeta(+) T and CD19(+) cell-depleted grafts from an HLA-haplo-identical donor","volume":"6","author":"Bertaina","year":"2017","journal-title":"Oncoimmunology."},{"key":"B95","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood."},{"key":"B96","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of alphabeta+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1182\/blood-2018-07-861575","article-title":"Unrelated donor vs HLA-haploidentical alpha\/beta T-cell- and B-cell-depleted HSCT in children with acute leukemia","volume":"132","author":"Bertaina","year":"2018","journal-title":"Blood."},{"key":"B98","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1182\/blood-2018-99-110124","article-title":"Results of a prospective, multicenter, phase I\/II clinical study in pediatric and adult patients using TCR alpha\/beta and CD19 depleted haploidentical hematopoietic stem cell grafts following reduced-intensity conditioning","volume":"132","author":"Lang","year":"2018","journal-title":"Blood."},{"key":"B99","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.coi.2013.09.003","article-title":"Lineage relationship of effector and memory T cells","volume":"25","author":"Restifo","year":"2013","journal-title":"Curr Opin Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.290.5489.92","article-title":"Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells","volume":"290","author":"Lanzavecchia","year":"2000","journal-title":"Science."},{"key":"B101","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1182\/blood-2007-08-109678","article-title":"Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease","volume":"111","author":"Zheng","year":"2008","journal-title":"Blood."},{"key":"B103","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.4049\/jimmunol.0802212","article-title":"Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia","volume":"182","author":"Zheng","year":"2009","journal-title":"J Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.4049\/jimmunol.179.10.6547","article-title":"Naive and memory T cells induce different types of graft-versus-host disease","volume":"179","author":"Dutt","year":"2007","journal-title":"J Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","article-title":"Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease","volume":"103","author":"Chen","year":"2004","journal-title":"Blood."},{"key":"B106","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1182\/blood-2011-07-367011","article-title":"Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution","volume":"118","author":"Li","year":"2011","journal-title":"Blood."},{"key":"B107","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.bbmt.2014.01.032","article-title":"Engineering human peripheral blood stem cell grafts that are depleted of naive T cells and retain functional pathogen-specific memory T cells","volume":"20","author":"Bleakley","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/bmt.2015.139","article-title":"Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies","volume":"50","author":"Triplett","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jaci.2014.08.019","article-title":"CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: a preliminary study","volume":"135","author":"Touzot","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1182\/blood.V87.11.4887.bloodjournal87114887","article-title":"Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool","volume":"87","author":"Gribben","year":"1996","journal-title":"Blood."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJM199906033402202","article-title":"Transplantation of anergic histoincompatible bone marrow allografts","volume":"340","author":"Guinan","year":"1999","journal-title":"N Engl J Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1182\/blood-2010-03-273193","article-title":"Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease","volume":"116","author":"Bastien","year":"2010","journal-title":"Blood."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/bmt.2011.237","article-title":"Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT","volume":"47","author":"Perruccio","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"B115","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bcmd.2007.06.022","article-title":"Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation","volume":"40","author":"Perruccio","year":"2008","journal-title":"Blood Cells Mol Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/bjh.15970","article-title":"Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis","volume":"186","author":"Roy","year":"2019","journal-title":"Br J Haematol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature."},{"key":"B118","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fimmu.2016.00188","article-title":"NK cells and other innate lymphoid cells in hematopoietic stem cell transplantation","volume":"7","author":"Vacca","year":"2016","journal-title":"Front Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity."},{"key":"B120","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science."},{"key":"B121","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.it.2017.12.001","article-title":"Natural killer cell education and the response to infection and cancer therapy: stay tuned","volume":"39","author":"Boudreau","year":"2018","journal-title":"Trends Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fimmu.2013.00015","article-title":"Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells","volume":"4","author":"Locatelli","year":"2013","journal-title":"Front Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"203628","DOI":"10.1155\/2011\/203628","article-title":"The structural basis of ligand recognition by natural killer cell receptors","volume":"2011","author":"Joyce","year":"2011","journal-title":"J Biomed Biotechnol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.humimm.2018.10.003","article-title":"Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop","volume":"79","author":"Misra","year":"2018","journal-title":"Hum Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.4049\/jimmunol.169.9.5118","article-title":"Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets","volume":"169","author":"Hsu","year":"2002","journal-title":"J Immunol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1034\/j.1600-065X.2002.19004.x","article-title":"The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism","volume":"190","author":"Hsu","year":"2002","journal-title":"Immunol Rev."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1101\/gr.137976.112","article-title":"Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors","volume":"22","author":"Jiang","year":"2012","journal-title":"Genome Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e15115","DOI":"10.1371\/journal.pone.0015115","article-title":"Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus","volume":"5","author":"Pyo","year":"2010","journal-title":"PLoS ONE."},{"key":"B130","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.4049\/jimmunol.174.10.6540","article-title":"Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors","volume":"174","author":"Leung","year":"2005","journal-title":"J Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2141.2011.08823.x","article-title":"Use of NK cell activity in cure by transplant","volume":"155","author":"Leung","year":"2011","journal-title":"Br J Haematol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.it.2011.06.001","article-title":"Unifying concepts of MHC-dependent natural killer cell education","volume":"32","author":"Elliott","year":"2011","journal-title":"Trends Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.smim.2006.03.003","article-title":"Missing self recognition and self tolerance of natural killer (NK) cells","volume":"18","author":"Raulet","year":"2006","journal-title":"Semin Immunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity."},{"key":"B135","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ni.1849","article-title":"'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection","volume":"11","author":"Orr","year":"2010","journal-title":"Nat Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1172\/JCI62749","article-title":"Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment","volume":"122","author":"Tarek","year":"2012","journal-title":"J Clin Invest."},{"key":"B137","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.4049\/jimmunol.0803900","article-title":"NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model","volume":"182","author":"Joncker","year":"2009","journal-title":"J Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.4049\/jimmunol.1502469","article-title":"KIR3DL1 and HLA-B density and binding calibrate NK education and response to HIV","volume":"196","author":"Boudreau","year":"2016","journal-title":"J Immunol."},{"key":"B139","first-page":"229","article-title":"Natural killer cells, HLA class I molecules, and marrow transplantation","volume":"3","author":"Valiante","year":"1997","journal-title":"Biol Blood Marrow Transplant."},{"key":"B140","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","article-title":"Determinants of antileukemia effects of allogeneic NK cells","volume":"172","author":"Leung","year":"2004","journal-title":"J Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.humimm.2007.01.019","article-title":"Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation","volume":"68","author":"McQueen","year":"2007","journal-title":"Hum Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1182\/blood-2008-07-171926","article-title":"Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia","volume":"113","author":"Cooley","year":"2009","journal-title":"Blood."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood."},{"key":"B144","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood."},{"key":"B145","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1200\/JCO.2016.70.7059","article-title":"KIR3DL1\/HLA-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation","volume":"35","author":"Boudreau","year":"2017","journal-title":"J Clin Oncol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1182\/blood-2005-04-1644","article-title":"KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation","volume":"106","author":"Cooley","year":"2005","journal-title":"Blood."},{"key":"B147","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood-2014-09-599993","article-title":"Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality","volume":"125","author":"Mancusi","year":"2015","journal-title":"Blood."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1182\/blood-2014-03-565069","article-title":"KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL","volume":"124","author":"Oevermann","year":"2014","journal-title":"Blood."},{"key":"B149","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.bbmt.2017.11.042","article-title":"Killer cell immunoglobulin-like receptor-ligand mismatch in donor versus recipient direction provides better graft-versus-tumor effect in patients with hematologic malignancies undergoing allogeneic T cell-replete haploidentical transplantation followed by post-transplant cyclophosphamide","volume":"24","author":"Wanquet","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B150","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/asheducation-2015.1.215","article-title":"Immune reconstitution following stem cell transplantation","volume":"2015","author":"van den Brink","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"B151","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/bmt.2012.211","article-title":"Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning","volume":"48","author":"DeCook","year":"2012","journal-title":"Bone Marrow Transplantation."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.bbmt.2016.04.015","article-title":"Higher early monocyte and total lymphocyte counts are associated with better overall survival after standard total body irradiation, cyclophosphamide, and fludarabine reduced-intensity conditioning double umbilical cord blood allogeneic stem cell transplantation in adults","volume":"22","author":"Le Bourgeois","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B154","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.bbmt.2019.01.003","article-title":"Monocyte subpopulation recovery as predictors of hematopoietic cell transplantation outcomes","volume":"25","author":"Turcotte","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B155","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11684-017-0548-1","article-title":"Comparison of reference values for immune recovery between event-free patients receiving haploidentical allografts and those receiving human leukocyte antigen-matched sibling donor allografts","volume":"12","author":"Pei","year":"2018","journal-title":"Front Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3389\/fimmu.2018.01841","article-title":"Joint modeling of immune reconstitution post haploidentical stem cell transplantation in pediatric patients with acute leukemia comparing CD34+-selected to CD3\/CD19-depleted grafts in a retrospective multicenter study","volume":"9","author":"Salzmann-Manrique","year":"2018","journal-title":"Front Immunol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1182\/blood.V88.10.4058.bloodjournal88104058","article-title":"Mortality hazard functions as related to neutropenia at different times after marrow transplantation","volume":"88","author":"Offner","year":"1996","journal-title":"Blood."},{"key":"B158","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s10875-011-9630-7","article-title":"Immune reconstitution following unmanipulated HLA-mismatched\/haploidentical transplantation compared with HLA-identical sibling transplantation","volume":"32","author":"Chang","year":"2012","journal-title":"J Clin Immunol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/bmt.2015.108","article-title":"Long-term outcome of HLA-haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion based on an FBCA conditioning regimen for hematologic malignancies","volume":"50","author":"Lin","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B160","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1182\/blood.V93.2.728","article-title":"Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation","volume":"93","author":"Fearnley","year":"1999","journal-title":"Blood."},{"key":"B161","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.4049\/jimmunol.1200093","article-title":"Primary MHC-class II+ cells are necessary to promote resting V\u03b42 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate and isopentenyl pyrophosphate","volume":"189","author":"Soriano-Sarabia","year":"2012","journal-title":"J Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.3389\/fimmu.2018.02528","article-title":"Dendritic cells are critical for the activation and expansion of V\u03b42+ T cells after allogeneic hematopoietic transplantation","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3390\/ijms17122081","article-title":"Antithymocyte globulin induces a tolerogenic phenotype in human dendritic cells","volume":"17","author":"Roider","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1567-5769(02)00253-9","article-title":"Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells","volume":"3","author":"Monti","year":"2003","journal-title":"Int Immunopharmacol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1200\/JCO.2012.47.4007","article-title":"Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation","volume":"31","author":"Bari","year":"2013","journal-title":"J Clin Oncol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3324\/haematol.2009.021121","article-title":"Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children","volume":"95","author":"Pfeiffer","year":"2010","journal-title":"Haematologica."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1189\/jlb.0613343","article-title":"At the bedside: innate immunity as an immunotherapy tool for hematological malignancies","volume":"94","author":"Locatelli","year":"2013","journal-title":"J Leukoc Biol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood."},{"key":"B170","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood."},{"key":"B171","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1182\/blood-2007-07-103325","article-title":"Temporal, quantitative, and functional characteristics of single-KIR\u2013positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation","volume":"112","author":"Vago","year":"2008","journal-title":"Blood."},{"key":"B172","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.it.2018.04.009","article-title":"NK cells mediate a crucial graft-versus-leukemia effect in haploidentical-HSCT to cure high-risk acute leukemia","volume":"39","author":"Locatelli","year":"2018","journal-title":"Trends Immunol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3324\/haematol.2015.134155","article-title":"Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing alphabeta+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies","volume":"101","author":"Muccio","year":"2016","journal-title":"Haematologica."},{"key":"B174","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3324\/haematol.2017.186619","article-title":"The early expansion of anergic NKG2Apos\/CD56dim\/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation","volume":"103","author":"Roberto","year":"2018","journal-title":"Haematologica."},{"key":"B176","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbmt.2007.02.010","article-title":"Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome","volume":"13","author":"Zhao","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbmt.2018.08.008","article-title":"Quantity and quality reconstitution of NKG2A+ natural killer cells are associated with graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"25","author":"Hu","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B178","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-0609.2007.00822.x","article-title":"Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients","volume":"78","author":"Zhao","year":"2007","journal-title":"Eur J Haematol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbmt.2012.08.014","article-title":"Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma","volume":"49","author":"Raiola","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.bbmt.2015.04.025","article-title":"Post-transplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and peripheral blood stem cells","volume":"21","author":"Cieri","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B181","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.bbmt.2014.11.075","article-title":"Comparable and robust immune reconstitution after HLA-haploidentical or HLA-matched allogeneic transplantation (BMT) utilizing posttransplantation cyclophosphamide","volume":"21","author":"McCurdy","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B182","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1182\/blood-2014-11-608406","article-title":"Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation","volume":"125","author":"Roberto","year":"2015","journal-title":"Blood."},{"key":"B183","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.seminhematol.2019.03.005","article-title":"Immune reconstitution after T-cell replete HLA-haploidentical transplantation","volume":"56","author":"McCurdy","year":"2019","journal-title":"Semin Hematol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"e0156777","DOI":"10.1371\/journal.pone.0156777","article-title":"Rapid recovery of CD3+CD8+ T cells on day 90 predicts superior survival after unmanipulated haploidentical blood and Marrow transplantation","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS ONE."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/sj.bmt.1705381","article-title":"Rapid helper T-cell recovery above 200 \u00d7 106\/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"B186","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41409-018-0351-x","article-title":"Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting","volume":"54","author":"Bondanza","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B187","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1182\/blood-2014-11-608539","article-title":"Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation","volume":"125","author":"Cieri","year":"2015","journal-title":"Blood."},{"key":"B188","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/bjh.14433","article-title":"Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review","volume":"176","author":"Fisher","year":"2017","journal-title":"Brit J Haematol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3+ CD4+ CD25+ regulatory T cells in patients with chronic graft-versus-host disease","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood."},{"key":"B190","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/leu.2014.180","article-title":"Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors","volume":"29","author":"Peccatori","year":"2015","journal-title":"Leukemia."},{"key":"B191","doi-asserted-by":"publisher","first-page":"e1242546","DOI":"10.1080\/2162402X.2016.1242546","article-title":"Lower incidence of acute GVHD is associated with the rapid recovery of CD4(+)CD25(+)CD45RA(+) regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: a retrospective (development) and prospective (validation) cohort-based study","volume":"5","author":"Wang","year":"2016","journal-title":"Oncoimmunology."},{"key":"B192","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"e23304","DOI":"10.4161\/onci.23304","article-title":"Human V\u03b42 versus non-V\u03b42 \u03b3\u03b4 T cells in antitumor immunity","volume":"2","author":"Kabelitz","year":"2013","journal-title":"OncoImmunology."},{"key":"B194","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1182\/blood-2010-01-255166","article-title":"The role of V\u03b42-negative \u03b3\u03b4 T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation","volume":"116","author":"Knight","year":"2010","journal-title":"Blood."},{"key":"B195","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00281-008-0132-5","article-title":"Reconstitution of the immune system after hematopoietic stem cell transplantation in humans","volume":"30","author":"Storek","year":"2008","journal-title":"Semin Immunopathol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/bmt.2014.266","article-title":"B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY","volume":"50","author":"Roberto","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B197","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMoa0811036","article-title":"Loss of mismatched HLA in leukemia after stem-cell transplantation","volume":"361","author":"Vago","year":"2009","journal-title":"N Engl J Med."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.bbmt.2017.05.031","article-title":"Clinical utility of quantitative PCR for chimerism and engraftment monitoring after allogeneic stem cell transplantation for hematologic malignancies","volume":"23","author":"Ahci","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/leu.2014.314","article-title":"Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation","volume":"29","author":"Crucitti","year":"2015","journal-title":"Leukemia."},{"key":"B200","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1038\/leu.2016.144","article-title":"Loss of the mismatched human leukocyte antigen haplotype in two acute myelogenous leukemia relapses after haploidentical bone marrow transplantation with post-transplantation cyclophosphamide","volume":"30","author":"McCurdy","year":"2016","journal-title":"Leukemia."},{"key":"B201","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat Med."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41467-019-08871-1","article-title":"Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT","volume":"10","author":"Noviello","year":"2019","journal-title":"Nat Commun."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.18.00130","article-title":"Review of haploidentical hematopoietic cell transplantation","volume":"4","author":"Khan","year":"2018","journal-title":"J Glob Oncol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(09)70074-9","article-title":"Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study","volume":"10","author":"Ciceri","year":"2009","journal-title":"Lancet Oncol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","article-title":"HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia","volume":"276","author":"Bonini","year":"1997","journal-title":"Science."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1182\/blood-2012-01-405670","article-title":"T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation","volume":"120","author":"Vago","year":"2012","journal-title":"Blood."},{"key":"B207","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1182\/blood-2004-11-4564","article-title":"An inducible caspase 9 safety switch for T-cell therapy","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible apoptosis as a safety switch for adoptive cell therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N Engl J Med."},{"key":"B209","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1182\/blood-2015-02-628354","article-title":"Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation","volume":"125","author":"Zhou","year":"2015","journal-title":"Blood."},{"key":"B210","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1182\/blood-2014-01-551671","article-title":"Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood."},{"key":"B211","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.bbmt.2013.11.020","article-title":"HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation","volume":"20","author":"Zeidan","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/s41409-018-0406-z","article-title":"Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patients","volume":"54","author":"Sun","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"B213","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00277-018-3482-7","article-title":"Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies","volume":"98","author":"Gao","year":"2019","journal-title":"Ann Hematol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fimmu.2014.00016","article-title":"Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells","volume":"5","author":"Bacchetta","year":"2014","journal-title":"Front Immunol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jcyt.2018.01.006","article-title":"Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells","volume":"20","author":"Muller","year":"2018","journal-title":"Cytotherapy."},{"key":"B216","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bbmt.2014.12.016","article-title":"Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions\u2013a retrospective multicenter analysis from the German Cooperative Transplant Study Group","volume":"21","author":"Schroeder","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B217","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00277-017-3185-5","article-title":"Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group","volume":"97","author":"Schroeder","year":"2018","journal-title":"Ann Hematol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med."},{"key":"B219","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood."},{"key":"B220","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","article-title":"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ymthe.2016.10.020","article-title":"Phase 1 results of ZUMA-1: a multicenter study of KTE-C19 anti-CD19 CAR T cell therapy in refractory aggressive lymphoma","volume":"25","author":"Locke","year":"2017","journal-title":"Mol Ther."},{"key":"B222","doi-asserted-by":"publisher","first-page":"eaaj2013","DOI":"10.1126\/scitranslmed.aaj2013","article-title":"Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells","volume":"9","author":"Qasim","year":"2017","journal-title":"Sci Transl Med."},{"key":"B223","first-page":"1083","article-title":"First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia","volume":"8","author":"Tang","year":"2018","journal-title":"Am J Cancer Res."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N Engl J Med."},{"key":"B225","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/2326-6066.CIR-18-0307","article-title":"Phase I trial of autologous CAR T cells targeting NKG2D ligands in patients with AML\/MDS and multiple myeloma","volume":"7","author":"Baumeister","year":"2019","journal-title":"Cancer Immunol Res."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/leu.2014.62","article-title":"Chimeric antigen receptors against CD33\/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo","volume":"28","author":"Pizzitola","year":"2014","journal-title":"Leukemia."},{"key":"B228","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.bbmt.2018.12.142","article-title":"Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation","volume":"25","author":"Copelan","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B229","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood."},{"key":"B230","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, epstein-barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41591-019-0472-9","article-title":"T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant","volume":"25","author":"Chapuis","year":"2019","journal-title":"Nat Med."},{"key":"B232","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1073\/pnas.0530192100","article-title":"Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia","volume":"100","author":"Marijt","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B233","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1182\/blood-2017-07-791608","article-title":"Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse","volume":"131","author":"Dossa","year":"2018","journal-title":"Blood."},{"key":"B234","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2017-08-752170","article-title":"Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation","volume":"131","author":"Cooley","year":"2018","journal-title":"Blood."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2017-05-785659","article-title":"Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation","volume":"130","author":"Ciurea","year":"2017","journal-title":"Blood."},{"key":"B236","doi-asserted-by":"publisher","first-page":"e0141864","DOI":"10.1371\/journal.pone.0141864","article-title":"Functional modulation of regulatory T cells by IL-2","volume":"10","author":"Moon","year":"2015","journal-title":"PLoS ONE."},{"key":"B237","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1182\/blood-2013-10-532531","article-title":"Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein","volume":"123","author":"Bachanova","year":"2014","journal-title":"Blood."},{"key":"B238","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1182\/bloodadvances.2018028332","article-title":"First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia","volume":"3","author":"Cooley","year":"2019","journal-title":"Blood Adv."},{"key":"B239","doi-asserted-by":"publisher","first-page":"357ra123","DOI":"10.1126\/scitranslmed.aaf2341","article-title":"Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia","volume":"8","author":"Romee","year":"2016","journal-title":"Sci Transl Med."},{"key":"B240","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1182\/blood-2012-04-419283","article-title":"Cytokine activation induces human memory-like NK cells","volume":"120","author":"Romee","year":"2012","journal-title":"Blood."},{"key":"B241","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1182\/blood-2017-12-823757","article-title":"First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation","volume":"131","author":"Romee","year":"2018","journal-title":"Blood."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00191\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T22:34:07Z","timestamp":1695767647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00191\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":241,"alternative-id":["10.3389\/fimmu.2020.00191"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00191","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"article-number":"191"}}